Tag: preclinical research
-
Preclinical Development and IND/CTA Readiness: making the candidate safe enough to test in people
This is Part 4 of The Drug Development Playbook. We talk about building nonclinical and CMC evidence that lets regulators say yes to first-in-human trials.
-
Hit Discovery and Lead Optimization – how teams turn a validated target into an actual drug candidate
This is Part 3 of The Drug Development Playbook. We answer the next question: how do you find molecules that not only hit that biology but can become safe, manufacturable medicines?
-
Disease Understanding and Target Identification: Picking the Biology Worth Backing
This is Part 2 of The Drug Development Playbook, an eight-part series on how medicines actually move from idea to patient use and how smarter decisions at each stage change outcomes.
-
From Idea to Patient: How Drug Development Actually Works
This is the first article in The Drug Development Playbook, an eight-part series on bringing a medicine from idea to patient use. Part 1 outlines the full journey, key stages, and where most programs fail, setting up practical deep dives into each phase that follow in the rest of the series.
Aryan Kenia 